Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE
|
|
- John Jackson
- 8 years ago
- Views:
Transcription
1 Sandro Sorbi DIPARTIMENTO DI SCIENZE NEUROLOGICHE E PSICHIATRICHE
2 L Ignoto, il Mistero, stimolano il pensiero, sono indispensabili al poeta ed all artista, aprono alla creatività. L Ignoto, il Mistero, sono un dono per gli umili, i semplici, i più, che li sentono come un emanazione divina e perciò non si fanno tante domande, come me in questa notte stellata, ma pregano e si mettono nelle mani di Dio. R. La Capria, Esercizi Superficiali. Nuotando in superficie. Mondadori,
3
4 L itinerario diagnostico L imaging, la biochimica liquorale, la genetica, l assessment, la storia. La diagnosi per prevenire? Per curare? Per dissipare dubbi e paure? Per emarginare? 4
5 DEMENZE PRESENILI Dementia prevalence rates for men and women in 9 different age groups Range di età : 250 / Range di età : 1600 /
6 All Causes of Degenerative Dementia Alzheimer s Disease 50-75% Vascular Dementia 25-50% Other Dementias 25% Of all causes Prevalence Rate 31,25 x Alzheimer Europe, Rare Forms of Dementia EC Project, 2005
7 «Other» Degenerative Dementias FAMILIAL ALZHEIMER DISEASE (FAD) FRONTO-TEMPORAL DEGENERATION (FTD) Fronto-temporal dementia (FTD) Primary Progressive Aphasia (PPA) Semantic Dementia (SD) FTD with parkinsonism linked to chromosome 17 (FTDP-17) Pick s disease (PiD) Dementia lacking distinctive histology (DLDH) LEWY BODY DISEASES DEMENTIA WITH LEWY BODIES (DLB) DEMENTIA IN PARKINSON S DISEASE (PDD) Both of these categories though cannot be considered as one single disease, but rather as a spectrum of different diseases, which would individually fall under the definition of rare diseases. CORTICOBASAL DEGENERATION (CBD) PROGRESSIVE SUPRANUCLEAR PALSY (PSP) ARGYROPHILIC GRAIN DISEASE (AGD) FAMILIAL BRITISH DEMENTIA FAMILIAL DANISH DEMENTIA POSTERIOR CORTICAL ATROPHY (BALINT) PRION DISEASES
8 Sorbi et al. EFNS guidelines for Dementia, 2012, in press
9 Need to test early intervention: The rapid growth of knowledge about the potential pathogenic mechanisms of AD. There is accruing evidence that, years before the onset of clinical symptoms, there is an AD process evolving along a predictable pattern of progression in the brain.. The neurobiological advantage of earlier intervention within this cascade is clear. Earlier intervention with disease-modifying therapies is likely to be more effective
10 Marker = Test diagnostico???
11 MEMORIA EPISODICA IPPOCAMPALE
12 PIB AMYLOID MCI OKELLO ET AL. NEUROLOGY, 2009 Seventeen of 31 (55%) subjects with MCI had increased 11C-PIB retention at baseline and 14 of these 17 (82%) clinically converted to AD during follow-up.
13 2332 non-selected brains from 1- to 100-year-old individuals. Of the total cases, 1,031 (44.2%) had β-amyloid plaques. The first plaques occurred in the neocortex after the onset of tauopathy. Tauopathy associated with sporadic Alzheimer disease anticipates amyloid deposition and may begin earlier than previously thought.
14 TAU PRECOCE E SPECIFICO BETA ASPECIFICO
15 NEUROIMAGE, 2012
16
17
18
19 Neurol Sci, 2011 The presence of episodic memory impairment is required for the diagnosis of Alzheimer s dementia by all current criteria. There must be objective evidence of significantly impaired episodic memory on testing, generally consisting of a recall deficit that does not improve significantly with cueing or recognition testing nor after effective encoding of information has been controlled. This neuropsychological feature has been recently proposed as the core criterion for the diagnosis of prodromal AD [4].
20 Neurological Sciences 2011
21
22 Test diagnostici?? Affidabilità? Validità?? Falsi positivi? Falsi negativi?
23 Neurological Sciances, 2012 After having critically revised the scientific evidence related to the new lexicon and to the new proposed diagnostic criteria, the panel concluded that the proposed new diagnostic criteria and the new proposed lexicon for AD are conceptually attractive. However, the evidence about the instrumental and laboratory markers for the diagnosis of the preclinical and asymptomatic states of the disease are, until to now, insufficient to support the routine clinical use of these investigations.
24 The Lancet Neurology, 2010 Giorgio Giaccone et al. on behalf of the BrainNet Europe consortium The proposed approach is fraught with three major problems: First, the concept of disease is inextricably associated with signs of malfunction and suffering (as per WHO s definition of disease). Second, there are uncertainties in clinical diagnosis.. Third, this lexicon does not take heed of the mixed pathological changes that underlie dementia and that seem to be more the rule than the exception In conclusion, we do not think that the knowledge available today is sufficient to define AD as proposed by Dubois and colleagues,
25
Primary Endpoints in Alzheimer s Dementia
Primary Endpoints in Alzheimer s Dementia Dr. Karl Broich Federal Institute for Drugs and Medical Devices (BfArM) Kurt-Georg-Kiesinger-Allee 38, D-53175 Bonn Germany Critique on Regulatory Decisions in
More informationSocial Security Disability Insurance and young onset dementia: A guide for employers and employees
Social Security Disability Insurance and young onset dementia: A guide for employers and employees What is Social Security Disability Insurance? Social Security Disability Insurance (SSDI) is a payroll
More information2016 Programs & Information
Mayo Alzheimer s Disease Research Clinic Education Center 2016 Programs & Information BROCHURE TITLE FLUSH RIGHT for Persons & Families impacted by Mild Cognitive Impairment Alzheimer s Disease Dementia
More informationPrimary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment
Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate
More informationCholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW
Cholinesterase inhibitors and memantine use for Alzheimer s disease TOPIC REVIEW Diagnosis of Dementia : DSM-IV criteria Loss of memory and one or more other cognitive abilities Aphasia Apraxia Agnosia
More informationNormal and Abnormal Aging and the Brain. Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD
Normal and Abnormal Aging and the Brain Joel Kramer, PsyD Saul Villeda, PhD Kristine Yaffe, MD The myth of cognitive decline The myth of cognitive decline Individual change varies Individual change varies
More information2014 Alzheimer s Disease Facts and Figures
2014 Alzheimer s Disease Facts and Figures Includes a Special Report on Women and Alzheimer s Disease Almost two-thirds of Americans with Alzheimer s disease are women. Alzheimer s Disease is the six eading
More informationDiagnosis and Initial Management of Cognitive Disorders
Diagnosis and Initial Management of Cognitive Disorders January 29, 2016 Kelly Garrett, PhD Cathleen Obray, MD, MHS Neurosciences Clinical Program Cognitive Care Team None Disclosures Neurosciences Clinical
More informationBiomarkers for Alzheimer's Disease in Down Syndrome
Biomarkers for Alzheimer's Disease in Down Syndrome Brad Christian, Ph.D. Waisman Laboratory for Brain Imaging Outline Rationale for Studying AD in Down Syndrome Background of Alzheimer s Disease Biomarkers
More informationUPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED 10-18-13
UPDATES TO NEUROCOGNITIVE DISORDERS IN DSM-5 and DSM-5 DESK REFERENCE UPDATED 10-18-13 SUMMARY: These coding changes ensure that insurance reimbursement can be obtained when the specifier With behavioral
More informationFrontotemporal Dementia: Clinicopathological Correlations
Frontotemporal Dementia: Clinicopathological Correlations Mark S. Forman, MD, PhD, 1,2 Jennifer Farmer, MS, 1 Julene K. Johnson, PhD, 3 Christopher M. Clark, MD, 2,4 Steven E. Arnold, MD, 2,4,5 H. Branch
More informationMalattia di Alzheimer: L importanza della Diagnosi e del Trattamento Precoce: la Collaborazione MMG-Specialista
55 Congresso Nazionale SIG Firenze Auditorium Palazzo dei Congressi 2 Dicembre 2010 Invecchiamento e Longevità: più Geni o più Ambiente Malattia di Alzheimer: L importanza della Diagnosi e del Trattamento
More information2015 Alzheimer s Disease Facts and Figures
2015 Alzheimer s Disease Facts and Figures Includes a Special Report on Disclosing a Diagnosis of Alzheimer s Disease Alzheimer s Disease is the sixth-leading cause of death in the United States. more
More informationDementia Causes and Neuropsychological Evaluation of the Older Adult
Dementia Causes and Neuropsychological Evaluation of the Older Adult Laurie N. Culp, Ph.D. Pate and Culp Psychological Assoc. 2440 Lawrenceville Highway Suite 200 Decatur, GA 30033 678-595-0062 lculp@emory.edu
More informationCommunity Network for Dementia and Critical Path in Japan
Research and Reviews Community Network for Dementia and Critical Path in Japan JMAJ 54(5): 305 309, 2011 Satoshi ORIMO* 1 Abstract In Setagaya City of Tokyo, regional hospitals and medical associations
More informationThe Genetic Basis of Neurological Disorders
The Genetic Basis of Neurological Disorders A complete advanced undergraduate/graduate course with: 22 online lectures by leading authorities Resources for workshops, tutorials, journal clubs, projects
More information2016 ALZHEIMER S DISEASE FACTS AND FIGURES
2016 ALZHEIMER S DISEASE FACTS AND FIGURES Includes a Special Report on the Personal Financial Impact of Alzheimer s on Families About this report 2016 Alzheimer s Disease Facts and Figures is a statistical
More information1 in 3 seniors dies with Alzheimer s or another dementia.
2013 Alzheimer s disease facts and figures Includes a Special Report on long-distance caregivers 1 in 3 seniors dies with Alzheimer s or another dementia. Out-of-pocket expenses for long-distance caregivers
More informationAge Associated Cognitive Decline and Mild Cognitive Impairment (MCI)
Age Associated Cognitive Decline and Mild Cognitive Impairment (MCI) Mike R. Schoenberg, PhD, ABPP-CN Diplomate, American Board of Clinical Neuropsychology Licensed Psychologist Departments of Psychiatry
More informationCognitive-Communication Disorders of Dementia
Cognitive-Communication Disorders of Dementia Definition, Diagnosis, and Treatment Second Edition Kathryn A. Bayles, PhD, CCC-SLP Cheryl K. Tomoeda, MS, CCC-SLP Contents Preface Acknowledgements Contributors
More informationMCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease
MCDB 4777/5777 Molecular Neurobiology Lecture 38 Alzheimer s Disease Outline of Today s Lecture Why is Alzheimer s disease a problem? What is Alzheimer s Disease? What causes Alzheimer s disease? How can
More informationIs there a Distinct Phenotype to Memory Loss in Alzheimer's Disease?
Is there a Distinct Phenotype to Memory Loss in Alzheimer's Disease? David A. Wolk, M.D. Assistant Director Penn Memory Center Assistant Professor of Neurology University of Pennsylvania 5 Million Clinical
More informationRare forms of dementia: Final Report
Rare forms of dementia: This project has received financial support from the European Commission. Neither the European Commission nor any person acting on its behalf is responsible for any use that might
More informationMagnetic Resonance Techniques in Neurodegenerative Diseases First Course Alzheimer s disease and frontotemporal lobar degeneration spectrum
Università Vita-Salute San Raffaele Neuroimaging Research Unit Institute of Experimental Neurology, Division of Neuroscience, San Raffaele Scientific Institute and Vita-Salute San Raffaele University Magnetic
More informationGuidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease
Guidance for Industry Alzheimer s Disease: Developing Drugs for the Treatment of Early Stage Disease DRAFT GUIDANCE This guidance document is being distributed for comment purposes only. Comments and suggestions
More informationCase Studies, MCI, Clinical Trials and Care Management Support
Case Studies, MCI, Clinical Trials and Care Management Support These slides form part of a Clinical Education programme. To benefit fully and earn CME credits, please contact clinician@re-cognitionhealth.com
More informationHow To Treat Aphasia
Taking first steps: towards a speech pathology management pathway for primary progressive aphasia. Cathleen Taylor 1, Karen Croot 2, & Lyndsey Nickels 3. 1. War Memorial Hospital, Waverley, AUSTRALIA,
More informationPDF hosted at the Radboud Repository of the Radboud University Nijmegen
PDF hosted at the Radboud Repository of the Radboud University Nijmegen The following full text is an author's version which may differ from the publisher's version. For additional information about this
More informationWhat Is Dementia? Type of Dementia
What Is Dementia? Dementia is a general term for a decline in mental ability severe enough to interfere with daily life. Memory loss is an example. Alzheimer's is the most common type of dementia. About
More informationBedside cognitive examination beyond the MMSE. Dr Richard Perry Dept of Neurosciences Imperial College
Bedside cognitive examination beyond the MMSE Dr Richard Perry Dept of Neurosciences Imperial College Overview Initial observations Cognitive rating scales Assessing cognitive domains Memory Language Visuospatial
More informationIII./3.1.2. Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases
III./3.1.2. Parkinsonian syndrome (parkinsonism, atypical parkinsonian disorders) in neurodegenerative diseases III./3.1.2.1. Multiple System Atrophy (MSA) MSA is a sporadic, adult onset degenerative neurological
More informationNEUROIMAGING in Parkinsonian Syndromes
NEUROIMAGING in Parkinsonian Syndromes (Focus on Structural Techniques: CT and MRI) Dr. Roberto Cilia Parkinson Institute, ICP, Milan, Italy OUTLINE Primary Parkinsonism Idiopathic Parkinson s Disease
More informationSimposio Internacional: International Symposium Murray Grossman
Murray Grossman Office Address: Department of Neurology - Gates 3 Hospital of the University of Pennsylvania Philadelphia, PA 19104-4283 If you are not a U.S. citizen please indicate the type of visa you
More informationAlzheimer s & Dementia 9 (2013) e1 e16
Alzheimer s & Dementia 9 (2013) e1 e16 Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer s Association
More informationMental health issues in the elderly. January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca
Mental health issues in the elderly January 28th 2008 Presented by Éric R. Thériault etheriau@lakeheadu.ca Cognitive Disorders Outline Dementia (294.xx) Dementia of the Alzheimer's Type (early and late
More informationIn conjunction with clinical history, structural
A QUICK GUIDE FOR NEUROIMAGING OF COMMON DEMENTIAS SEEN IN CLINICAL PRACTICE PRINT THIS ARTICLE David F. Tang-Wai, MDCM, FRCPC, assistant professor of neurology and geriatric medicine at the University
More informationANXIETY & COGNITIVE IMPAIRMENT
ANXIETY & COGNITIVE IMPAIRMENT Dr. Sherri Hayden, Ph.D., R. Psych. Neuropsychologist, UBC Hospital Clinic for Alzheimer Disease & Related Disorders Clinical Assistant Professor, UBC Department of Medicine,
More informationUnmet Needs for Parkinson s Disease Therapeutics
Unmet Needs for Parkinson s Disease Therapeutics Coalition Against Major Diseases & FDA Workshop October 20, 2014 Caroline M Tanner MD, PhD Director, Parkinson's Disease Research Education and Clinical
More informationAlzheimer s disease. What is Alzheimer s disease?
Alzheimer s disease What is Alzheimer s disease? What we know about dementia and Alzheimer s disease Alzheimer s disease is the most common of a large group of disorders known as dementias. It is an irreversible
More informationJ/601/2874. This unit must be assessed in accordance with Skills for Care and Development s QCF Assessment Principles.
Unit 13: Dementia Awareness Unit code: DEM 201 Unit reference number: J/601/2874 QCF level: 2 Credit value: 2 Guided learning hours: 17 Unit summary The aim of the unit is to enable learners to gain knowledge
More informationSteps to getting a diagnosis: Finding out if it s Alzheimer s Disease.
Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have
More informationCRITERIA FOR AD DEMENTIA June 11, 2010
CRITERIA F AD DEMENTIA June 11, 2010 Alzheimer s Disease Dementia Workgroup Guy McKhann, Johns Hopkins University (Chair) Bradley Hyman, Massachusetts General Hospital Clifford Jack, Mayo Clinic Rochester
More informationAlzheimer s Australia Submission on the Draft Report of the Productivity Commission Inquiry into Disability Care and Support
Disability Care and Support Inquiry Productivity Commission GPO Box 1428 Canberra City ACT 2601 Alzheimer s Australia Submission on the Draft Report of the Productivity Commission Inquiry into Disability
More informationDementia & Movement Disorders
Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia
More information2011 Alzheimer s Disease Facts and Figures
2012 Alzheimer s disease facts and figures 2011 Alzheimer s Disease Facts and Figures Includes a special report on early detection and diagnosis Includes a Special Report on People with Alzheimer s Disease
More informationPatients in England with a record of dementia diagnosis on their clinical record: February 2016. Quality and Outcomes Framework dementia subset
Patients in England with a record of dementia diagnosis on their clinical record: February 2016 Quality and Outcomes Framework dementia subset Published March 2016 We are the trusted national provider
More informationMemory Rehabilitation in Early Dementia. Diana Golvers Clinical Psychologist Central Dementia Service
Memory Rehabilitation in Early Dementia Diana Golvers Clinical Psychologist Central Dementia Service Loss of Memory in AD Memory impairment earliest manifestation of AD and other dementias Major impact
More informationGOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY BE AN EFFECTIVE TREATMENT FOR ALZHEIMER S DISEASE AND VASCULAR DEMENTIA
CONTACT: Alzheimer s Association AAIC newsroom, 202-249-4002, media@alz.org Niles Frantz, Alzheimer s Association, 312-335-5777, niles.frantz@alz.org GOING BEYOND RISK REDUCTION: PHYSICAL EXERCISE MAY
More informationDementia Episodes of Care
A Guide for Bundled Payments This document reviews the considerations in establishing a bundled payment program for services provided to patients with dementia. In addressing dementia, there are two distinct
More informationParticipating in Alzheimer s Disease Clinical Trials and Studies
Participating in Alzheimer s Disease Clinical Trials and Studies FACT SHEET When Margaret was diagnosed with earlystage Alzheimer s disease at age 68, she wanted to do everything possible to combat the
More informationJohns Hopkins Memory & Alzheimer s Treatment Center
Memory is The Memory Center has not only provided great care to my husband, but also has helped me learn to care for myself while caring for him. - Sylvia Mackey Have you forgotten someone s name you should
More informationCognitive impairment (CI) in Multiple Sclerosis
Multiple Sclerosis and Mild Cognitive Impairment What are the cognitive impairments in MS and why are the terms dementia and Mild Cognitive Impairment (MCI) rarely used? By Ronald Devere, MD Cognitive
More informationStefano F. Cappa Department of Neuroclinical Sciences Vita Salute University and San Raffaele Scientific Institute Milan, Italy
Stefano F. Cappa Department of Neuroclinical Sciences Vita Salute University and San Raffaele Scientific Institute Milan, Italy Declared no potential conflict of interest. CLINICAL HETEROGENEITY Stefano
More informationDementia One Day Essentials 2015
Dementia One Day Essentials 2015 1 Dementia One Day Essentials 2015 2 At Risk of Dementia: Mild Cognitive Impairment and Other Non-Dementia Diagnoses Dr Jill Rasmussen Declaration of Interests NHS: GP
More informationObjectives. Aging and Forgetfulness Define Dementia Types of Dementia Treatment
Dementia David Lam, MD, FRCPC, Psychiatry Assistant Clinical Professor Department of Psychiatry and Behavioural Neurosciences McMaster University Hamilton, Ontario Objectives Aging and Forgetfulness Define
More informationAlzheimer s and Depression: What is the Connection?
Alzheimer s and Depression: What is the Connection? Ladson Hinton MD Professor and Director of Geriatric Psychiatry Department of Psychiatry and Behavioral Sciences Director, Education Core, Alzheimer
More informationDementia and Delirium:
Dementia and Delirium: A Neurologist s Approach to Altered Mental Status S. Andrew Josephson MD Carmen Castro-Franceschi and Gladyne K. Mitchell Neurohospitalist Distinguished Professor Vice Chairman,
More informationAlzheimer s disease. The importance of early diagnosis
Alzheimer s disease The importance of early diagnosis Key Facts Alzheimer s disease and other dementias 1 Alzheimer's disease is the leading form of dementia and accounts for 50%-75% of all cases. 1 Vascular
More information9/20/2010. The eye doesn t see what the mind doesn t know. Sir William Osler
The eye doesn t see what the mind doesn t know. Sir William Osler Lewy Body Dementia Atypical Dementia The Lewy Body Spectrum Patricia J. Gifford, MD Silverado Hospice 2009 Progressive loss of intellectual
More informationOHTAC Recommendation
OHTAC Recommendation Multiple Sclerosis and Chronic Cerebrospinal Venous Insufficiency Presented to the Ontario Health Technology Advisory Committee in May 2010 May 2010 Issue Background A review on the
More information09/05/2014. Painting pictures of the brain with numbers. Overview
Painting pictures of the brain with numbers Neurology for Insurers Dr Ian Cox & Adele Groyer (Gen Re) Overview Critical Illness Product Background Why should we be interested in neurology? Consult our
More informationUnderstanding the Genetics of FTD
Understanding the Genetics of FTD A guide for patients and their families Acknowledgements The authors wish to acknowledge the following centers and associations which contributed to the creation of this
More informationREHABILITATION MEDICINE by PROFESSOR ANTHONY WARD
REHABILITATION MEDICINE by PROFESSOR ANTHONY WARD What is Rehabilitation Medicine? Rehabilitation Medicine (RM) is the medical specialty with rehabilitation as its primary strategy. It provides services
More informationClinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project
Tohoku J. Exp. Med., 2008, 215, 125-131 MCI and Dementia in a Community 125 Review Clinical Features of Mild Cognitive Impairment and Dementia in a Community: An update of the Osaki-Tajiri Project KENICHI
More information2014 Neurologic Physical Therapy Professional Education Consortium Webinar Course Descriptions and Objectives
Descriptions and Neuroplasticity Health care providers are facing greater time restrictions to render services to the individual with neurological dysfunction. However, the scientific community has recognized
More informationCurriculum Vitae. Board Certification: American Board of Professional Psychology Clinical Neuropsychology and Pediatric Neuropsychology
Place of Birth: Washington, DC Curriculum Vitae Karen Spangenberg Postal, Ph.D., ABPP-CN 166 North Main Street Suite 3B Andover, MA 01810 (978) 475-2025 E-mail: karenpostal@comcast.net Board Certification:
More informationDiagnostic Decision Support by Intelligent Medical Image Retrieval with Electronic Medical Record for Dementia Treatment Enhancement
350 MEDICAL IMAGING TECHNOLOGY Vol.25 No.5 November 2007 特 集 論 文 / ONCO-MEDIA Diagnostic Decision Support by Intelligent Medical Image Retrieval with Electronic Medical Record for Dementia Treatment Enhancement
More informationPrescribing Framework for Donepezil in the Treatment and Management of Dementia
Hull & East Riding Prescribing Committee Prescribing Framework for Donepezil in the Treatment and Management of Dementia Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker) GP
More informationAlzheimer s & Dementia 7 (2011) 280 292
Alzheimer s & Dementia 7 (2011) 280 292 Toward defining the preclinical stages of Alzheimer s disease: Recommendations from the National Institute on Aging-Alzheimer s Association workgroups on diagnostic
More informationCognitive Testing for Underwriting Life Insurance
Cognitive Testing for Underwriting Life Insurance Presentation to the Mortality Working Group of the International Actuarial Association Al Klein April 8, 2011 Cognitive function Agenda What is it? What
More informationCognitive Deficits in the Early Stages of Alzheimer s Disease Martha Storandt
CURRENT DIRECTIONS IN PSYCHOLOGICAL SCIENCE Cognitive Deficits in the Early Stages of Alzheimer s Disease Martha Storandt Washington University in St. Louis ABSTRACT Evidence from longitudinal, experimental,
More informationSubject Review. p.17 Alzheimer s Disease: An Update. p.21 Diabetes Team and Glycemic Control DANIEL A. LLANO, MD, PHD
Subject Review p.17 DANIEL A. LLANO, MD, PHD p.21 Diabetes Team and Glycemic Control MICHAEL JAKOBY, MD, MA, FACP ANN GAREY, NP ROBERT KIRBY, MD KINGSLEY ONYEMERE, MD, MPH JAMES KUMAR, MD RENATO ALCARAZ,
More informationdoi:10.1093/brain/awr179 Brain 2011: 134; 2456 2477 2456
doi:10.1093/brain/awr179 Brain 2011: 134; 2456 2477 2456 BRAIN A JOURNAL OF NEUROLOGY Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia Katya Rascovsky,
More informationWhy study clinical neuropsychology?
University Leiden, The Netherlands Master (MSc) in Clinical Neuropsychology H.A.M.Middelkoop@lumc.nl www.neuropsychologie.leidenuniv.nl Why study clinical neuropsychology? You are interested in: brain/behavior
More informationBEHAVIORAL INTERVENTIONS IN ELDERLY POPULATIONS WITH DEMENTIA: A REVIEW OF RELEVANT FACTORS. Kristen D. Braun. 79 pages July 2011
i BEHAVIORAL INTERVENTIONS IN ELDERLY POPULATIONS WITH DEMENTIA: A REVIEW OF RELEVANT FACTORS Kristen D. Braun 79 pages July 2011 This review summarizes selected literature related to dementia in the elderly
More informationWhat is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician
What is PD? Dr Catherine Dotchin MD MRCP Consultant Geriatrician Overview of presentation Case history Video example pre and post treatment Historical review PD in the UK Epidemiology and aetiology Making
More informationNeuropsychological Assessment of Early Cognitive Impairment in the Elderly
Neuropsychological Assessment of Early Cognitive Impairment in the Elderly David Loewenstein PhD, ABPP/CN Professor of Psychiatry and Behavioral Sciences Department of Psychiatry, Miller School of Medicine,
More informationThe John Hopkins Behavioral Neurology and Neuropsychiatry Fellowship Program Mission Statement:
The John Hopkins Behavioral Neurology and Neuropsychiatry Fellowship Program Mission Statement: The Behavioral Neurology and Neuropsychiatry Fellowship Program at the Johns Hopkins School of Medicine is
More informationMILD COGNITIVE DISORDERS 1 DEMENTIA SCREENING 6/27/2007 DEMENTIA SCREENING IS IT A GOOD IDEA TO SCREEN PATIENTS FOR EARLY DEMENTIA?
MILD COGNITIVE DISORDERS 1 DEMENTIA SCREENING IS IT A GOOD IDEA TO SCREEN PATIENTS FOR EARLY DEMENTIA? Prevailing opinions on the subject are mixed. Identification of the patient with presymptommatic dementia
More informationAutomatic Morphological Analysis of the Medial Temporal Lobe
Automatic Morphological Analysis of the Medial Temporal Lobe Neuroimaging analysis applied to the diagnosis and prognosis of the Alzheimer s disease. Andrea Chincarini, INFN Genova Clinical aspects of
More informationIntellectual Symptoms Amnesia: Loss of memory function
Definition of Dementia (de mens) Latin for out of mind Permanent loss of multiple intellectual functions Alois Alzheimer first described this disease in 1906 in a brain specimen from an autopsy. Alzheimer
More informationRecommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4)
CLINICAL PRACTICE GUIDELINES/CONCENSUS STATEMENTS Recommendations of the 4th Canadian Consensus Conference on the Diagnosis and Treatment of Dementia (CCCDTD4) Serge Gauthier, MD, Christopher Patterson,
More informationChanging the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars
Changing the Trajectory of Alzheimer s Disease: How a Treatment by 2025 Saves Lives and Dollars The appendices for this report including a detailed description of the model developed by The Lewin Group;
More information1: Motor neurone disease (MND)
1: Motor neurone disease (MND) This section provides basic facts about motor neurone disease (MND) and its diagnosis. The following information is an extracted section from our full guide Living with motor
More informationLearning and cognitive effects of acquired brain injury caused by meningitis or septicaemia
Learning and cognitive effects of acquired brain injury caused by meningitis or septicaemia Meningitis and septicaemia can be a cause of acquired brain injury (ABI). This is an injury to the brain that
More informationMontreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi.
Montreal Cognitive Assessment (MoCA) as Screening tool for cognitive impairment in mtbi. Suresh Kumar, M.D. AUTHOR Director of: Neurology & Headaches Center Inc. Neurocognitve &TBI Rehabilitation Center
More informationDOTT. GIOVANNI CARLESIMO ELENCO DELLE PUBBLICAZIONI ANNI 2008-2013
DOTT. GIOVANNI CARLESIMO ELENCO DELLE PUBBLICAZIONI ANNI 2008-2013 1. P. Turriziani, M. Oliveri, S. Salerno, F. Costanzo, G. Koch, C. Caltagirone, G. A. Carlesimo. Recognition memory and prefrontal cortex:
More informationCognitive Interventions for Mild Cognitive Impairment
Cognitive Interventions for Mild Cognitive Impairment Kelly Murphy, PhD Neuropsychology & Cognitive Health, Baycrest Health Sciences Psychology Department, University of Toronto Aging & Speech Communication:
More informationMULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION
MULTIMODAL THERAPY FOR MS- ASSOCIATED COGNITIVE DYSFUNCTION Michael K. Racke, MD Professor and Chairman in Neurology The Helen C. Kurtz Chair in Neurology Department of Neurology Ohio State University
More informationOregon Project Independence Guidelines
Oregon Project Independence Guidelines The guide is to inform contractors of the key policies and procedures of the Oregon Project Independence Program. ACTION REQUIRED: District Centers are responsible
More informationERA-Net COFUND Research Programmes on Rare Diseases (E-RARE)
Bologna 15 Dicembre 2014 ERA-Net COFUND Research Programmes on Rare Diseases (E-RARE) The Role of RER-ASSR Antonio Addis Research Governance Area Agenzia Sanitaria e Sociale Regionale How do Regions might
More informationTHEORIES OF NEUROLOGICAL AGING AND DEMENTIA
THEORIES OF NEUROLOGICAL AGING AND DEMENTIA Aging Overview The primary care physician must advise middle-age and older patients about ways to age successfully. Dementia is a common disabling illness that
More informationBy Sarah Walter, M.S. ADNI Coordinating Center, Alzheimer s Disease Cooperative Study with assistance from the ADNI MRI Core and ADNI PET Core.
The National Cell Repository is a repository for families with Alzheimer s Disease or severe memory loss. Families having two or more living individuals with memory loss are encouraged to participate.
More informationRetinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease
Retinal Imaging Biomarkers for Early Diagnosis of Alzheimer s Disease Eleonora (Nora) Lad, MD, PhD Assistant Professor of Ophthalmology, Vitreoretinal diseases Duke Center for Macular Diseases Duke University
More informationObjectives. Evaluation of Memory Loss. Cognitive Impairment. Clinical Questions. Medicare Wellness Visit
Evaluation of Memory Loss and Mild Cognitive Impairment Skotti Church, MD Geriatrics Grand Rounds 4/3/2014 Objectives 1. Describe recommendations and tools for evaluation of cognitive impairment 2. Define
More informationMontreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych.
Montreal Cognitive Assessment (MoCA) Debbie Froese, B.M.R.-O.T., B.A. Christine Knight, Ph.D.,R.Psych. Community Geriatric Mental Health Model of Continuum of Cognition with Aging Normal Mild cognitive
More informationMEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION. POLICY NUMBER: 8.01.19 CATEGORY: Therapy/Rehabilitation
MEDICAL POLICY SUBJECT: COGNITIVE REHABILITATION PAGE: 1 OF: 5 If the member's subscriber contract excludes coverage for a specific service it is not covered under that contract. In such cases, medical
More informationPeople with PPA can experience many different types of language symptoms.
What is PPA? Primary progressive aphasia (PPA) is a form of cognitive impairment that involves a progressive loss of language function. Language is a uniquely human faculty that allows us to communicate
More informationMA IN REHABILITATION IN LANGUAGE AND SPEECH PATHOLOGY (TAUGHT IN BULGARIAN)
MA IN REHABILITATION IN LANGUAGE AND SPEECH PATHOLOGY (TAUGHT IN BULGARIAN) Brief presentation of the program: The program is aimed at training specialists in treatment of children, adolescents and adults
More informationA Support System for Diagnosis of Dementia, Alzheimer or Mild Cognitive Impairment
Toronto, November 4, 2013 04:00 pm 05:30 pm-4th Oral Session A Support System for Diagnosis of Dementia, Alzheimer or Mild Cognitive Impairment Flávio L. Seixas Aura Conci Débora C. Muchaluat Saade Bianca
More information